Search Results - "Benny Klimek, Margaret"
-
1
Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice
Published in PloS one (23-05-2016)“…Duchenne muscular dystrophy (DMD) is an X-linked muscle disease caused by mutations in the dystrophin gene. The pathology of DMD manifests in patients with…”
Get full text
Journal Article -
2
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
Published in Biochemical and biophysical research communications (15-01-2010)“…Cachexia, progressive loss of fat and muscle mass despite adequate nutrition, is a devastating complication of cancer associated with poor quality of life and…”
Get full text
Journal Article -
3
Morpholino‐induced exon skipping stimulates cell‐mediated and humoral responses to dystrophin in mdx mice
Published in The Journal of pathology (01-07-2019)“…Exon skipping is a promising genetic therapeutic strategy for restoring dystrophin expression in the treatment of Duchenne muscular dystrophy (DMD). The…”
Get full text
Journal Article -
4
Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J mice
Published in Journal of the neurological sciences (15-09-2015)“…Abstract The dysferlin-deficient A/J mouse strain represents a homologous model for limb-girdle muscular dystrophy 2B. We evaluated the disease phenotype in 10…”
Get full text
Journal Article -
5
Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy
Published in Journal of neuromuscular diseases (01-01-2021)“…Phosphorodiamidate morpholino oligomer (PMO)-mediated exon skipping is currently used in clinical development to treat Duchenne muscular dystrophy (DMD), with…”
Get more information
Journal Article -
6
Effect of the IL-1 Receptor Antagonist Kineret.sup.® on Disease Phenotype in mdx Mice
Published in PloS one (23-05-2016)“…Duchenne muscular dystrophy (DMD) is an X-linked muscle disease caused by mutations in the dystrophin gene. The pathology of DMD manifests in patients with…”
Get full text
Journal Article -
7
Elusive sources of variability of dystrophin rescue by exon skipping
Published in Skeletal muscle (01-12-2015)“…Systemic delivery of anti-sense oligonucleotides to Duchenne muscular dystrophy (DMD) patients to induce de novo dystrophin protein expression in muscle (exon…”
Get full text
Journal Article -
8
Molecular mechanisms of heart valve and skeletal muscle development and disease
Published 01-01-2013“…Heart valves function to provide unidirectional blood flow during each cardiac cycle. The development of the heart valves from embryonic stages is a highly…”
Get full text
Dissertation -
9
Abstract 5101: Acute inhibition of myostatin-family proteins preserves muscle in cancer cachexia
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Cachexia, progressive loss of fat and muscle mass despite adequate nutrition, is a devastating complication of cancer associated with poor quality of life and…”
Get full text
Journal Article -
10
Molecular mechanisms of heart valve and skeletal muscle development and disease
Get full text
Dissertation